enVVeno Medical Corporation (NVNO)

CIK 0001661053 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 —
Q1-2026 8-K (2026-04-29) · 99.1
Latest FY-2025 8-K (2026-02-04) · 99.1
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
FY-2024
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Balance Sheets
Consolidated Balance Sheets
Balance Sheets (P)
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Statements of Operations
Condensed Consolidated Statements of Changes In Stockholders' Equity (deficiency) (unaudited)
—
Condensed Statements of Changes In Stockholders' Equity (deficiency) (unaudited)
—
Consolidated Statements of Changes In Stockholders' Equity
—
Statements of Changes In Stockholders' Equity
Consolidated Statements of Cash Flows
Statements of Cash Flows
Notes
Accounts Payable Accrued Expenses and Other Current Liabilities
—
Accounts Payable, Accrued Expenses and Other Current Liabilities
Award Timing Disclosure
—
Business Organization and Nature of Operations
Commitments and Contingencies
Concentrations
Cybersecurity Risk Management and Strategy Disclosure
—
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Investments
Managements Liquidity Plan
Net Loss Per Share
Pay Vs Performance Disclosure
Property and Equipment
Recovery of Erroneously Awarded Compensation
—
Right-of-use Assets and Lease Liabilities
—
Right-of-use Assets and Liabilities
—
Segment Reporting
Share Based Compensation
—
Significant Accounting Policies
Stock-based Compensation
—
Stockholders Equity
Subsequent Events